• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症和感染:两个不应混淆的词。

Sepsis and infection: Two words that should not be confused.

作者信息

Vincent Jean-Louis

机构信息

Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

出版信息

Front Med (Lausanne). 2023 Mar 9;10:1156732. doi: 10.3389/fmed.2023.1156732. eCollection 2023.

DOI:10.3389/fmed.2023.1156732
PMID:36968843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10033658/
Abstract

The underlying cause of sepsis is a dysregulated host response to infection, leading to multiple organ failure. Identifying sepsis is crucial because of the associated pathophysiological, practical, and therapeutic implications, which will determine where and how the patient should be managed. In the absence of an end-of-life decision to limit therapies, the patient should be admitted to the intensive care unit immediately. Importantly, not all patients with sepsis are the same and being able to better characterize them is important. The future will focus on phenotypes to characterize critically ill patients, with or without infection, to enable more appropriate targeting of therapeutic interventions.

摘要

脓毒症的根本原因是宿主对感染的反应失调,进而导致多器官功能衰竭。由于脓毒症具有相关的病理生理、实际操作及治疗方面的影响,这些影响将决定患者的管理地点及方式,因此识别脓毒症至关重要。在没有限制治疗的临终决定的情况下,患者应立即入住重症监护病房。重要的是,并非所有脓毒症患者都相同,能够更好地对他们进行特征描述很重要。未来将聚焦于对危重症患者(无论有无感染)进行特征描述的表型,以便更精准地靶向治疗干预措施。

相似文献

1
Sepsis and infection: Two words that should not be confused.脓毒症和感染:两个不应混淆的词。
Front Med (Lausanne). 2023 Mar 9;10:1156732. doi: 10.3389/fmed.2023.1156732. eCollection 2023.
2
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
3
Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges.脓毒症相关性器官功能障碍的病理生理学和分子基础的最新进展:新的治疗意义和挑战。
Pharmacol Ther. 2017 Sep;177:56-66. doi: 10.1016/j.pharmthera.2017.02.040. Epub 2017 Feb 21.
4
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南:2012 年。
Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.
5
Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children.儿童序贯器官衰竭评估评分的适应性与验证及危重症儿童中脓毒症-3定义的评估
JAMA Pediatr. 2017 Oct 2;171(10):e172352. doi: 10.1001/jamapediatrics.2017.2352.
6
[Septic cardiomyopathy: pathophysiology and potential new therapeutic approaches].[脓毒症性心肌病:病理生理学及潜在的新治疗方法]
Nihon Yakurigaku Zasshi. 2018;151(3):111-116. doi: 10.1254/fpj.151.111.
7
Clinical Sepsis Phenotypes in Critically Ill Patients.重症患者的临床脓毒症表型
Microorganisms. 2023 Aug 27;11(9):2165. doi: 10.3390/microorganisms11092165.
8
High-volume haemofiltration for sepsis in adults.成人脓毒症的高容量血液滤过
Cochrane Database Syst Rev. 2017 Jan 31;1(1):CD008075. doi: 10.1002/14651858.CD008075.pub3.
9
The impact of age on the innate immune response and outcomes after severe sepsis/septic shock in trauma and surgical intensive care unit patients.年龄对创伤和外科重症监护病房严重脓毒症/脓毒性休克患者固有免疫反应和结局的影响。
J Trauma Acute Care Surg. 2018 Aug;85(2):247-255. doi: 10.1097/TA.0000000000001921.
10
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients.美国胸科医师学会/危重病医学会关于严重创伤患者的全身炎症反应综合征及相关病症的共识会议定义
Crit Care Med. 1997 Nov;25(11):1789-95. doi: 10.1097/00003246-199711000-00014.

引用本文的文献

1
Molecular Mechanisms Underlying Inflammation in Early-Onset Neonatal Sepsis: A Systematic Review of Human Studies.早发型新生儿败血症炎症的分子机制:人类研究的系统综述
J Clin Med. 2025 Jul 28;14(15):5315. doi: 10.3390/jcm14155315.
2
Neonatal Sepsis: A Comprehensive Review.新生儿败血症:全面综述
Antibiotics (Basel). 2024 Dec 25;14(1):6. doi: 10.3390/antibiotics14010006.
3
Lactate-enhanced-qSOFA (LqSOFA) score as a predictor of in-hospital mortality in patients with sepsis: systematic review and meta-analysis.乳酸增强型快速序贯器官衰竭评估(LqSOFA)评分作为脓毒症患者院内死亡率的预测指标:系统评价与荟萃分析

本文引用的文献

1
Current sepsis therapeutics.当前脓毒症治疗方法。
EBioMedicine. 2022 Dec;86:104318. doi: 10.1016/j.ebiom.2022.104318. Epub 2022 Dec 2.
2
Evolution of the Concept of Sepsis.脓毒症概念的演变
Antibiotics (Basel). 2022 Nov 9;11(11):1581. doi: 10.3390/antibiotics11111581.
3
The End of "One Size Fits All" Sepsis Therapies: Toward an Individualized Approach.“一刀切”式脓毒症治疗的终结:迈向个体化治疗方法
Eur J Trauma Emerg Surg. 2025 Jan 24;51(1):33. doi: 10.1007/s00068-024-02757-8.
4
Mid-Regional Pro-Adrenomedullin Can Predict Organ Failure and Prognosis in Sepsis?中肾肽能否预测脓毒症器官衰竭和预后?
Int J Mol Sci. 2023 Dec 13;24(24):17429. doi: 10.3390/ijms242417429.
5
Insight Into Neonatal Sepsis: An Overview.新生儿败血症概述
Cureus. 2023 Sep 19;15(9):e45530. doi: 10.7759/cureus.45530. eCollection 2023 Sep.
6
Changes in Cortisol Secretion and Corticosteroid Receptors in COVID-19 and Non COVID-19 Critically Ill Patients with Sepsis/Septic Shock and Scope for Treatment.新冠病毒感染和非新冠病毒感染的脓毒症/脓毒性休克重症患者的皮质醇分泌及糖皮质激素受体变化与治疗前景
Biomedicines. 2023 Jun 23;11(7):1801. doi: 10.3390/biomedicines11071801.
Biomedicines. 2022 Sep 12;10(9):2260. doi: 10.3390/biomedicines10092260.
4
Prospective international validation of the predisposition, infection, response and organ dysfunction (PIRO) clinical staging system among intensive care and general ward patients.在重症监护病房和普通病房患者中对易感性、感染、反应和器官功能障碍(PIRO)临床分期系统进行前瞻性国际验证。
Ann Intensive Care. 2021 Dec 23;11(1):180. doi: 10.1186/s13613-021-00966-7.
5
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.拯救脓毒症运动:2021年脓毒症和脓毒性休克国际管理指南
Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2.
6
Blood lactate levels in sepsis: in 8 questions.脓毒症患者的血乳酸水平:8 个问题。
Curr Opin Crit Care. 2021 Jun 1;27(3):298-302. doi: 10.1097/MCC.0000000000000824.
7
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率,1990-2017 年:全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
8
Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis.欧洲和北美的脓毒性休克发病率和死亡率:系统评价和荟萃分析。
Crit Care. 2019 May 31;23(1):196. doi: 10.1186/s13054-019-2478-6.
9
Sepsis and septic shock.脓毒症与脓毒性休克。
Nat Rev Dis Primers. 2016 Jun 30;2:16045. doi: 10.1038/nrdp.2016.45.
10
The Host Response in Patients with Sepsis Developing Intensive Care Unit-acquired Secondary Infections.脓毒症患者发生 ICU 获得性二次感染的宿主反应。
Am J Respir Crit Care Med. 2017 Aug 15;196(4):458-470. doi: 10.1164/rccm.201606-1225OC.